EMR showing upside potential

٢ فبراير ٢٠٢٣

Emerson is half way into the cycle with price target ranging from $93 to $96. I expect earnings to be good, but the recent indication for a hostile acquisition might overshadow the ER. I believe this will trend in a range until mid March when this could start its next leg up.

Disclaimer: My opinion on stocks are mine alone and not to be taken as Investment advice.